These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3123252)

  • 21. Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate.
    Rajapakse C; Thompson R; Grennan DM; Winston BM; Patel P; Nuttall PM; Murphy J; Weiss JB
    Ann Rheum Dis; 1983 Apr; 42(2):138-41. PubMed ID: 6221703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
    Fogelman I; Bessent RG; Turner JG; Citrin DL; Boyle IT; Greig WR
    J Nucl Med; 1978 Mar; 19(3):270-5. PubMed ID: 564941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone turnover determined by urinary excretion of [99mTc]diphosphonate in the prediction of postmenopausal bone loss.
    Thomsen K; Rødbro P; Christiansen C
    Bone Miner; 1987 Apr; 2(2):125-31. PubMed ID: 3504724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone mineralization and bone mineral content in primary hyperparathyroidism.
    Tougaard L; Hau C; Rodbro P; Ditzel J
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):314-9. PubMed ID: 576347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone metabolism and bone status in osteoporotic patients.
    Hartwell D; Riis BJ; Christiansen C; Thomsen K; Johansen JS; Rødbro P
    Acta Med Scand; 1987; 222(5):453-8. PubMed ID: 3425398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twenty-four-hour whole-body retention of 47Ca-chloride: an index of global bone metabolism in rat models.
    Seto H; Ihara F; Kakishita M
    Int J Rad Appl Instrum B; 1989; 16(8):799-804. PubMed ID: 2621115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal uptake of diphosphonate. Method for prediction of post-menopausal osteoporosis.
    Fogelman I; Bessent RG; Cohen HN; Hart DM; Lindsay R
    Lancet; 1980 Sep; 2(8196):667-70. PubMed ID: 6106785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
    Hyldstrup L; McNair P; Ring P; Henriksen O
    Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD.
    Valkema R; Vismans FJ; Papapoulos SE; Pauwels EK; Bijvoet OL
    Bone Miner; 1989 Jan; 5(2):183-92. PubMed ID: 2920240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum kinetics, bioavailability and bone scanning of 99mTc-labelled sodium olpadronate in patients with different rates of bone turnover.
    Degrossi OJ; Ortiz M; Degrossi EB; García del Río H; Barreira JC; Messina D; Kerzberg E; Roldán EJ; Montuori E; Pérez Lloret A
    Eur J Clin Pharmacol; 1995; 48(6):489-94. PubMed ID: 8582468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)].
    Knop J; Montz R
    Nuklearmedizin; 1983 Oct; 22(5):226-31. PubMed ID: 6228781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 99mTc-MDP retention in osteoporosis: relationship to other indices of bone cell activity and response to calcium and vitamin D therapy.
    Davie MW; Britton JM; Haddaway M; McCall IW
    Eur J Nucl Med; 1987; 13(9):462-6. PubMed ID: 3440471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total and local bone mineral during estrogen treatment: a placebo controlled trial.
    Gotfredsen A; Riis BJ; Christiansen C
    Bone Miner; 1986 Apr; 1(2):167-73. PubMed ID: 3334206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium metabolism in postmenopausal osteoporosis: the influence of dietary calcium and net absorbed calcium.
    Hasling C; Charles P; Jensen FT; Mosekilde L
    J Bone Miner Res; 1990 Sep; 5(9):939-46. PubMed ID: 2281824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
    Amerling R; Harbord NB; Pullman J; Feinfeld DA
    Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium kinetic investigations and their clinical use.
    Roth P; Hansen C; Werner E
    Appl Radiat Isot; 1998; 49(5-6):687-9. PubMed ID: 9569580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A refined method for assessing 99mTc-MDP whole body retention in prostate cancer patients.
    Castronovo FP; Prout GR; Strauss HW; McKusick KA; Griffin PP
    Int J Rad Appl Instrum B; 1987; 14(5):475-7. PubMed ID: 3667311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive evaluation of bone formation: measurements of serum alkaline phosphatase, whole body retention of diphosphonate and serum osteocalcin in metabolic bone disorders and thyroid disease.
    Hyldstrup L; Clemmensen I; Jensen BA; Transbøl I
    Scand J Clin Lab Invest; 1988 Nov; 48(7):611-9. PubMed ID: 3264412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of bone mineral density and content to mineral content and density of the fat-free mass.
    Evans EM; Prior BM; Arngrimsson SA; Modlesky CM; Cureton KJ
    J Appl Physiol (1985); 2001 Nov; 91(5):2166-72. PubMed ID: 11641358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.